Anticounterfeiting, Track and Trace Systems

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Global supply chain experts examine implications of the DSCSA as well as topical considerations around the EU's FMD in this serialization video series ft. manufacturing, packaging, software, and regulatory experts.

Low- and middle-income countries are at the greatest risk of receiving substandard and falsified COVID-19 vaccines.

BlackBerry’s QNX real-time operating system may create cybersecurity vulnerabilities, according to FDA.

The agency is endorsing recommendations for global track-and-trace systems developed by the International Coalition of Medicines Regulatory Authorities.

Drug product security requires anti-counterfeiting techniques such as authentication throughout the supply chain.

After Brexit there is an increased risk of the UK being exposed to counterfeit medicines, but regulations implementing blockchain as infrastructure technology could be the answer.

Dosage-level authentication provides an added digital layer of security for pharmaceutical companies to ensure their products are not exposed to falsification.

Labeling, printing, and on-dose tagging technologies provide a multi-layered approach to anticounterfeiting for pharmaceuticals.

Anticounterfeiting technology protects the supply chain from manufacturer to patient.

Industry wants clarification on compliance following the end of the Brexit transition period.

FDA, US Customs and Border Protection, and the US Immigration and Customs Enforcement, Homeland Security Investigations signed a Memorandum of Understanding to prevent illegal drug imports from entering the US through International Mail Facilities.

End-to-end traceability can provide more value than just securing drug product safety.

A strategic serialization partnership has been announced by advanco and Syntegon, aimed at tackling the global issue of counterfeit drugs.

Broader application of RFID in pharmaceutical packaging benefits caregivers and patients.

Advances in intelligent technologies for pharmaceutical packaging improve online productivity, authenticate product, and boost patient adherence.

Developer and supplier of film coating systems and excipients, Colorcon, has launched a new platform of on-dose technologies and detection services for the authentication of medications.

Molecular taggants from Applied DNA Sciences and Colorcon’s Opadry coating target counterfeit and falsified medications.

A coalition establishes a secure, direct link between a physical tablet and a digital backend for supply chain integrity.

Automated, electronic systems for raw materials tracking improve efficiency and prevent mistakes in biopharma manufacturing.

Under an agreement, Colorcon will incorporate TruTag’s edible microtag technology in its coatings.

Machine vision systems have been an integral part of pharma manufacturing and packaging for many years and, with the introduction of stricter safety regulations, are set to become more vital.

TraceLink will participate in the agency’s Pilot Project Program under the Drug Supply Chain Security Act.

The Marchesini Group will introduce the CMP pharma inspection system to the US market at INTERPHEX 2019.

Supply chain players are eligible to participate in FDA’s pilot program to develop an electronic system for tracking drug products.

The EU FMD deadline is closing in, so now is the time to look beyond the short term.

Active and intelligent packaging technologies benefit brand owners, caregivers, and patients.

Adents' DispaX offers improved supply-chain traceability for pharmaceutical warehouses, wholesalers, distributors, and dispensers such as pharmacies and hospitals.

In preparation for the upcoming US Drug Supply Chain Security Act deadline, Metrics Contract Services has expanded serialization capabilities at its oral solid-dose commercial manufacturing site in Greenville, NC.

New FDA guidance offers a time buffer but increases supply-chain-management complexity, as active DSCSA enforcement begins.